...
首页> 外文期刊>Critical care : >Intensive insulin treatment improves forearm blood flow in critically ill patients: a randomized parallel design clinical trial
【24h】

Intensive insulin treatment improves forearm blood flow in critically ill patients: a randomized parallel design clinical trial

机译:胰岛素强化治疗可改善危重患者的前臂血流:一项随机平行设计临床试验

获取原文
   

获取外文期刊封面封底 >>

       

摘要

IntroductionIntensive insulin treatment of critically ill patients was seen as a promising method of treatment, though recent studies showed that reducing the blood glucose level below 6 mmol/l had a detrimental outcome. The mechanisms of the effects of insulin in the critically ill are not completely understood. The purpose of the study was to test the hypothesis that intensive insulin treatment may influence forearm blood flow independently of global hemodynamic indicators.MethodsThe study encompassed 29 patients of both sexes who were admitted to the intensive care unit due to sepsis and required artificial ventilation as the result of acute respiratory failure. 14 patients were randomly selected for intensive insulin treatment (Group 1; blood glucose concentration 4.4-6.1 mmol/l), and 15 were selected for conventional insulin treatment (Group 2; blood glucose level 7.0 mmol/l-11.0 mmol/l). At the start of the study (t0, beginning up to 48 hours after admittance and the commencement of artificial ventilation), at 2 hours (t1), 24 hours (t2), and 72 hours (t3) flow in the forearm was measured for 60 minutes using the strain-gauge plethysmography method. Student's t-test of independent samples was used for comparisons between the two groups, and Mann-Whitney's U-test where appropriate. Linear regression analysis and the Pearson correlation coefficient were used to determine the levels of correlation.ResultsThe difference in 60-minute forearm flow at the start of the study (t0) was not statistically significant between groups, while at t2 and t3 significantly higher values were recorded in Group 1 (t2; Group 1: 420.6 ± 188.8 ml/100 ml tissue; Group 2: 266.1 ± 122.2 ml/100 ml tissue (95% CI 30.9-278.0, P = 0.02); t3; Group 1: 369.9 ± 150.3 ml/100 ml tissue; Group 2: 272.6 ± 85.7 ml/100 ml tissue (95% CI 5.4-190.0, P = 0.04). At t1 a trend towards significantly higher values in Group 1 was noted (P = 0.05). The level of forearm flow was related to the amount of insulin infusion (r = 0.40).ConclusionsCompared to standard treatment, intensive insulin treatment of critically ill patients increases forearm flow. Flow increase was weakly related to the insulin dose, though not to blood glucose concentration.Trial RegistrationTrial number: ISRCTN39026810.
机译:前言危重病人的强化胰岛素治疗被认为是一种有前途的治疗方法,尽管最近的研究表明,将血糖水平降低至6 mmol / l以下会有不利的结果。胰岛素对重症患者的作用机制尚未完全了解。该研究的目的是检验以下假设:强化胰岛素治疗可能独立于总体血流动力学指标而影响前臂血流。方法该研究包括29名因败血症而需要重症监护而需要人工通气的男女。急性呼吸衰竭的结果。随机选择14名患者进行强化胰岛素治疗(第1组;血糖浓度4.4-6.1 mmol / l),并选择15例进行常规胰岛素治疗(第2组;血糖水平7.0 mmol / l-11.0 mmol / l)。在研究开始时(t0,开始至入院后48小时并开始人工通气),分别在前2小时(t1),24小时(t2)和72小时(t3)测量前臂血流。使用应变仪体积描记法60分钟。比较两组的独立样本的学生t检验,并在适当的情况下使用Mann-Whitney的U检验进行比较。结果:研究开始时(t0)前臂流动60分钟的差异(t0)在各组之间无统计学意义,而在t2和t3时,两组之间的差异显着高,这是通过线性回归分析和Pearson相关系数确定的。在第1组中记录(t2;第1组:420.6±188.8 ml / 100 ml组织;第2组:266.1±122.2 ml / 100 ml组织(95%CI 30.9-278.0,P = 0.02); t3;第1组:369.9± 150.3 ml / 100 ml组织;第2组:272.6±85.7 ml / 100 ml组织(95%CI 5.4-190.0,P = 0.04)。在t1时,第1组的值有明显升高的趋势(P = 0.05)。结论与标准治疗相比,重症患者的强化胰岛素治疗增加了前臂血流量,与标准治疗相比,前臂血流量与胰岛素剂量呈弱相关,尽管与血糖无关。浓度试注册号:ISRCTN39026810。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号